» Articles » PMID: 30679596

TGF-β-SNAIL Axis Induces Müller Glial-mesenchymal Transition in the Pathogenesis of Idiopathic Epiretinal Membrane

Overview
Journal Sci Rep
Specialty Science
Date 2019 Jan 26
PMID 30679596
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

The epithelial-mesenchymal transition (EMT) is a key process in fibrogenic diseases where transdifferentiated myofibroblasts produce excessive amounts of extracellular matrix, resulting in organ dysfunction. Idiopathic epiretinal membrane (iERM) is a vision-threatening disorder characterized by fibrocellular proliferation and contraction on the central retina. Müller glial cells, which regulate retinal physiology and structure, are the major cellular components in the iERM tissue; however, the pathological role of this cell type remains incompletely understood. Here we revealed the involvement of Müller glial-mesenchymal transition (GMT), as an alternative to EMT, in the pathogenesis of iERM lacking epithelial contribution in nature. Of various pro-fibrotic cytokines, transforming growth factor (TGF)-β1 stimulation to human Müller glial cells exclusively increased mRNA and protein levels of several EMT-related molecular markers, together with the transcription factor SNAIL but not SLUG or TWIST. TGF-β1-stimulated Müller cells also exhibited EMT-related cell motility, while reducing the expression of glutamine synthetase (GS), a Müller glial marker. Notably, all of these TGF-β-induced EMT features were reversed by SNAI1 knockdown in Müller cells. iERM patient specimens demonstrated co-immunolocalization of SNAIL with TGF-β1, GS, and smooth muscle protein 22. Our data implicated a critical role of the TGF-β-SNAIL axis in Müller GMT to promote iERM formation.

Citing Articles

Fibrotic Changes in Rhegmatogenous Retinal Detachment.

Harju N, Kauppinen A, Loukovaara S Int J Mol Sci. 2025; 26(3).

PMID: 39940795 PMC: 11817287. DOI: 10.3390/ijms26031025.


Regional Alterations in Müller Cell Protein Expression in Human and a Rat Model of Geographic Atrophy.

Naik P, McLeod D, Bhutto I, Edwards M Invest Ophthalmol Vis Sci. 2025; 66(2):21.

PMID: 39918478 PMC: 11809446. DOI: 10.1167/iovs.66.2.21.


Suprachoroidal injection of triamcinolone acetonide as adjuvant to surgical treatment of epiretinal membrane.

Morescalchi F, Gandolfo F, Romano V, Baldi A, Semeraro F Int J Retina Vitreous. 2025; 11(1):2.

PMID: 39789636 PMC: 11720571. DOI: 10.1186/s40942-024-00623-8.


Epiretinal Membrane: Correlations Among Clinical, Immunohistochemical, and Biochemical Features and Their Prognostic Implications.

Yang H, Choi S, Kim S, Min C, Kim D, Lee Y Invest Ophthalmol Vis Sci. 2024; 65(14):25.

PMID: 39661356 PMC: 11636661. DOI: 10.1167/iovs.65.14.25.


Immunohistochemical expression of Fibrillin-1 in idiopathic epiretinal membranes.

Tien L, Yamamoto M, Tagami M, Misawa N, Honda S Graefes Arch Clin Exp Ophthalmol. 2024; 263(2):415-424.

PMID: 39466436 DOI: 10.1007/s00417-024-06667-8.


References
1.
Ishida S, Yamazaki K, Shinoda K, Kawashima S, Oguchi Y . Macular hole retinal detachment in highly myopic eyes: ultrastructure of surgically removed epiretinal membrane and clinicopathologic correlation. Retina. 2000; 20(2):176-83. View

2.
Ishida S, Shinoda K, Kawashima S, Oguchi Y, Okada Y, Ikeda E . Coexpression of VEGF receptors VEGF-R2 and neuropilin-1 in proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci. 2000; 41(7):1649-56. View

3.
Limb G, Salt T, Munro P, Moss S, Khaw P . In vitro characterization of a spontaneously immortalized human Müller cell line (MIO-M1). Invest Ophthalmol Vis Sci. 2002; 43(3):864-9. View

4.
de Iongh R, Wederell E, Lovicu F, McAvoy J . Transforming growth factor-beta-induced epithelial-mesenchymal transition in the lens: a model for cataract formation. Cells Tissues Organs. 2005; 179(1-2):43-55. DOI: 10.1159/000084508. View

5.
Kase S, Saito W, Yokoi M, Yoshida K, Furudate N, Muramatsu M . Expression of glutamine synthetase and cell proliferation in human idiopathic epiretinal membrane. Br J Ophthalmol. 2005; 90(1):96-8. PMC: 1856891. DOI: 10.1136/bjo.2005.078394. View